This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Glaxosmithkline Biologicals Sa, Novartis Ag. Active years: 2015-2021.
Location History:
- Siena, IT (2015)
- Monteriggioni, IT (2020 - 2021)
Company Filing History:
Years Active: 2015-2021
Title: The Innovative Contributions of Elena Mori
Introduction
Elena Mori is a distinguished inventor based in Monteriggioni, Italy. She has made significant contributions to the field of vaccine development, particularly in the analysis of meningococcal vaccines. With a total of 3 patents to her name, her work has had a profound impact on public health.
Latest Patents
One of her notable inventions is the "Vitro potency assay for protein-based meningococcal vaccines." This invention utilizes ELISA or similar assays to analyze meningococcal vaccines. The assay employs antibodies that bind to meningococcal proteins within the vaccine, specifically monoclonal antibodies that are bactericidal for meningococcus and/or recognize conformational epitopes within the meningococcal proteins. By conducting the assay on a series of dilutions of a test vaccine and comparing the results with those obtained from a reference vaccine of known potency, it is possible to determine the relative potency of the test vaccine. This value serves as a crucial parameter for assessing whether a manufactured batch of a vaccine is suitable for public release or if it has encountered a production failure and should not be used.
Career Highlights
Elena has worked with prominent companies in the pharmaceutical industry, including GlaxoSmithKline Biologicals SA and Novartis AG. Her experience in these organizations has allowed her to refine her expertise in vaccine development and potency assays.
Collaborations
Elena has collaborated with esteemed colleagues such as Marzia Monica Giuliani and Enrico Luzzi. These partnerships have further enhanced her research and innovation in the field.
Conclusion
Elena Mori's contributions to vaccine analysis and development are invaluable. Her innovative patents and collaborations reflect her commitment to improving public health through scientific advancements.

